Barclays PLC Buys 51,781 Shares of Amedisys, Inc. (NASDAQ:AMED)

Barclays PLC lifted its stake in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 333.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 67,310 shares of the health services provider's stock after buying an additional 51,781 shares during the period. Barclays PLC owned about 0.21% of Amedisys worth $6,112,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in the company. Blue Trust Inc. grew its holdings in shares of Amedisys by 55.1% during the 4th quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock worth $34,000 after purchasing an additional 124 shares in the last quarter. HBW Advisory Services LLC bought a new stake in Amedisys in the 4th quarter valued at $38,000. Versant Capital Management Inc raised its stake in shares of Amedisys by 68.5% in the 4th quarter. Versant Capital Management Inc now owns 450 shares of the health services provider's stock valued at $41,000 after buying an additional 183 shares in the last quarter. Vestcor Inc bought a new position in shares of Amedisys during the 4th quarter worth about $73,000. Finally, Venturi Wealth Management LLC boosted its position in shares of Amedisys by 397.4% during the 4th quarter. Venturi Wealth Management LLC now owns 975 shares of the health services provider's stock valued at $89,000 after acquiring an additional 779 shares in the last quarter. 94.36% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

AMED has been the subject of several recent research reports. Royal Bank of Canada reissued an "outperform" rating and issued a $100.00 price target on shares of Amedisys in a research report on Wednesday, April 16th. Stephens reaffirmed an "equal weight" rating and issued a $101.00 price target on shares of Amedisys in a research note on Tuesday, March 4th. Four equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $100.75.

Amedisys Price Performance

Shares of NASDAQ:AMED traded up $0.20 during trading on Thursday, reaching $95.10. The stock had a trading volume of 110,554 shares, compared to its average volume of 406,482. The stock has a market capitalization of $3.12 billion, a PE ratio of 37.74, a P/E/G ratio of 1.78 and a beta of 0.89. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19. Amedisys, Inc. has a 52 week low of $82.15 and a 52 week high of $98.95. The business's 50-day moving average price is $92.41 and its 200 day moving average price is $91.78.

Amedisys (NASDAQ:AMED - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The health services provider reported $1.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.13 by $0.12. The firm had revenue of $594.78 million during the quarter, compared to the consensus estimate of $597.43 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The business's revenue for the quarter was up 4.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.03 EPS. As a group, equities analysts predict that Amedisys, Inc. will post 4.4 earnings per share for the current year.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.